1. Home
  2. GOSS vs OZ Comparison

GOSS vs OZ Comparison

Compare GOSS & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • OZ
  • Stock Information
  • Founded
  • GOSS 2015
  • OZ 2020
  • Country
  • GOSS United States
  • OZ United States
  • Employees
  • GOSS N/A
  • OZ N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • OZ
  • Sector
  • GOSS Health Care
  • OZ
  • Exchange
  • GOSS Nasdaq
  • OZ Nasdaq
  • Market Cap
  • GOSS 262.5M
  • OZ 237.6M
  • IPO Year
  • GOSS 2019
  • OZ N/A
  • Fundamental
  • Price
  • GOSS $1.49
  • OZ $66.00
  • Analyst Decision
  • GOSS Strong Buy
  • OZ
  • Analyst Count
  • GOSS 3
  • OZ 0
  • Target Price
  • GOSS $7.33
  • OZ N/A
  • AVG Volume (30 Days)
  • GOSS 2.6M
  • OZ 1.3K
  • Earning Date
  • GOSS 08-11-2025
  • OZ 01-01-0001
  • Dividend Yield
  • GOSS N/A
  • OZ N/A
  • EPS Growth
  • GOSS N/A
  • OZ N/A
  • EPS
  • GOSS N/A
  • OZ N/A
  • Revenue
  • GOSS $124,590,000.00
  • OZ $4,077,000.00
  • Revenue This Year
  • GOSS N/A
  • OZ N/A
  • Revenue Next Year
  • GOSS $91.14
  • OZ N/A
  • P/E Ratio
  • GOSS N/A
  • OZ N/A
  • Revenue Growth
  • GOSS N/A
  • OZ 94.70
  • 52 Week Low
  • GOSS $0.66
  • OZ $56.77
  • 52 Week High
  • GOSS $1.55
  • OZ $82.89
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 61.04
  • OZ 53.49
  • Support Level
  • GOSS $1.20
  • OZ $64.39
  • Resistance Level
  • GOSS $1.39
  • OZ $67.02
  • Average True Range (ATR)
  • GOSS 0.09
  • OZ 0.77
  • MACD
  • GOSS 0.00
  • OZ -0.00
  • Stochastic Oscillator
  • GOSS 82.91
  • OZ 70.76

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

Share on Social Networks: